Janssen Files Application For Adult Indication Of AD/HD Drug Concerta
This article was originally published in PharmAsia News
Executive Summary
Janssen Pharmaceuticals has filed an application for the additional indication of its AD/HD drug Concerta (methylphenidate sustained-release tablets) for the treatment of over 18-year-old adults, the company announced March 19.